Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Pote...
Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy
About this item
Full title
Author / Creator
Zarubin, Aleksei , Stepanov, Vadim , Markov, Anton , Kolesnikov, Nikita , Marusin, Andrey , Khitrinskaya, Irina , Swarovskaya, Maria , Litvinov, Sergey , Ekomasova, Natalia , Dzhaubermezov, Murat , Maksimova, Nadezhda , Sukhomyasova, Aitalina , Shtygasheva, Olga , Khusnutdinova, Elza , Radzhabov, Magomed and Kharkov, Vladimir
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
The human serine protease serine 2 TMPRSS2 is involved in the priming of proteins of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a possible target for COVID-19 therapy. The TMPRSS2 gene may be co-expressed with SARS-CoV-2 cell receptor genes angiotensin-converting enzyme 2 (ACE2) and Basigin (BSG), but only TMPRS...
Alternative Titles
Full title
Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7823984
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7823984
Other Identifiers
ISSN
2073-4425
E-ISSN
2073-4425
DOI
10.3390/genes12010019
